FDA Recommends Additional Anti-Infection Measures for Duodenoscopes

The U.S. Food and Drug Administration announced it is providing a detailed list of additional reprocessing measures to be utilized by hospitals and other health-care facilities on duodenoscopes, which have been linked to outbreaks of the “superbug” bacteria CRE in hospitals across the country. Duodenoscopes – flexible, lighted tubes that are threaded through the mouth, throat, and stomach into the top of the small intestine – can accumulate bacteria that are not removed during conventional cleaning, allowing infections to be passed among patients. An FDA-convened expert panel recommended that hospitals and health-care facilities take one or more additional steps to further reduce the risk of infection. [8/4/15]